OTCMKTS:CNBX

CNBX Pharmaceuticals (CNBX) Stock Forecast, Price & News

$0.02

0.00 (0.00%)

(As of 06/1/2023 ET)

Compare

Today's Range: $0.02
▼
$0.03
50-Day Range: $0.01
▼
$0.09
52-Week Range: $0.01
▼
$5.50

Volume: 444,161 shs
Average Volume: 487,074 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Financials Headlines SEC Filings Short Interest

About CNBX Pharmaceuticals (OTCMKTS:CNBX) Stock

CNBX Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. The company was founded by Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.

Receive CNBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CNBX Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CNBX Stock News Headlines

March 29, 2023 | americanbankingnews.com

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Update

November 8, 2022 | benzinga.com

CNBX Acquires A Controlling Interest In Cancer Immunotherapy Developer

June 1, 2023 | Edge On The Street (Ad)

Graphite Shortage Could Derail the $7 Trillion EV Transition

Graphite (not lithium) is expected to see the largest increase in demand of all battery metals over the next decade. But projections warn of an 8 million ton shortfall of graphite by 2040. That's why 97 more graphite mines are needed just to keep up with battery production for the $7 trillion transition to electric vehicles.

November 8, 2022 | finance.yahoo.com

CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma

October 18, 2022 | finance.yahoo.com

CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy

October 13, 2022 | finance.yahoo.com

CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel

September 28, 2022 | finance.yahoo.com

CNBX Pharmaceuticals Announces New Patent Granted in Australia

September 12, 2022 | reuters.com

CNBX Pharmaceuticals Inc

June 1, 2023 | Edge On The Street (Ad)

The $193 Billion US-China War You Don't Know About

They're fighting for control of lithium – a key ingredient in EVs and clean energy technology. It's arguably the most important commodity of the 21st century. China owns 80% of global supply. But the US plans to grab a massive slice of the lithium market, which is forecasted to quadruple to $193 billion by 2028, according to Fortune Business Insights.

August 16, 2022 | ca.finance.yahoo.com

CNBX Pharmaceuticals Inc. (CNBX)

June 10, 2022 | benzinga.com

CNBX Pharmaceuticals (OTC:CNBXD), Earnings Estimates, EPS, and Revenue

June 10, 2022 | benzinga.com

CNBX Pharmaceuticals (OTC:CNBXD), Analyst Ratings, Price Targets, Predictions

June 7, 2022 | finance.yahoo.com

CNBX Pharmaceuticals Inc. (CNBXD)

May 31, 2022 | finance.yahoo.com

CNBX Pharmaceuticals Release a New Corporate Presentation

May 14, 2022 | barrons.com

CNBX Pharmaceuticals Inc.

May 5, 2022 | seekingalpha.com

CNBX pharma granted patent in Hong Kong for cancer therapy

May 5, 2022 | finance.yahoo.com

CNBX Pharmaceuticals Granted Patent in Hong Kong

April 4, 2022 | msn.com

Novartis to save at least $1 billion by 2024 thanks to simplified structure

April 4, 2022 | msn.com

Vertex Pharma sees positive results in Phase 2 trials of new non-opioid pain killer

April 4, 2022 | cnbc.com

What to watch today: Wall Street looks higher; Twitter soars on Elon Musk stake

April 4, 2022 | msn.com

Stocks making the biggest moves in the premarket: Twitter, Tesla, Starbucks and more

April 1, 2022 | cnbc.com

CNBC Transcript: Johnson & Johnson CEO Joaquin Duato Speaks with CNBC’s Meg Tirrell Live During CNBC’s Healthy Returns Summit Today

April 1, 2022 | cnbc.com

What to watch today: Wall Street set to wrap up strong month but weak quarter

April 1, 2022 | msn.com

Stocks making the biggest moves premarket: Walgreens, Baidu, Novavax and others

April 1, 2022 | msn.com

Vertex Pharmaceuticals reports positive data on non-opioid pain medicine

March 28, 2022 | finance.yahoo.com

Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals

November 30, 2021 | benzinga.com

Avicanna To Bring Its Cannabinoid-Based Drugs To Argentina Via 'Established' Pharma Partner

See More Headlines

CNBX Price History

30 days | 90 days | 365 days | Advanced Chart

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Biotechnology
Sub-Industry: Cannabis
Sector: Medical
Current Symbol: OTCMKTS:CNBX
CUSIP: N/A
CIK: 1343009
Web: www.cannabics.com
Phone: (877) 424-2429
Fax: N/A
Employees: 10
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Gabriel Yariv
Executive Chairman, President & COO

Eyal Barad
Chief Executive Officer & Director

Uri Ben-Or
Chief Financial Officer

Ilan Hochman
Vice President-Research & Development

Sanja Goldberg
Chief Technology Officer

Key Competitors

View All Competitors

CNBX Stock - Frequently Asked Questions

How have CNBX shares performed in 2023?: CNBX Pharmaceuticals' stock was trading at $1.86 at the beginning of the year. Since then, CNBX stock has decreased by 98.9% and is now trading at $0.02.
View the best growth stocks for 2023 here.
When did CNBX Pharmaceuticals' stock split?: Shares of CNBX Pharmaceuticals reverse split before market open on Thursday, May 12th 2022. The 1-120 reverse split was announced on Thursday, May 12th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.
What other stocks do shareholders of CNBX Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other CNBX Pharmaceuticals investors own include Gran Tierra Energy (GTE), Organigram (OGI), KushCo (KSHB), Pennsylvania Real Estate Investment Trust (PEI), Medical Marijuana (MJNA), Auxly Cannabis Group (CBWTF), American Cannabis (AMMJ), GreenGro Technologies (GRNH), MassRoots (MSRT) and Surna (SRNA).

What is CNBX Pharmaceuticals' stock symbol?: CNBX Pharmaceuticals trades on the OTCMKTS under the ticker symbol "CNBX."
How do I buy shares of CNBX Pharmaceuticals?: Shares of CNBX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is CNBX Pharmaceuticals' stock price today?: One share of CNBX stock can currently be purchased for approximately $0.02.
How can I contact CNBX Pharmaceuticals?: CNBX Pharmaceuticals' mailing address is #3 Bethesda Metro Center, Suite 700, BETHESDA, MD 20814, United States. The official website for the company is www.cannabics.com. The company can be reached via phone at (877) 424-2429.

This page (OTCMKTS:CNBX) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

CNBX Pharmaceuticals (CNBX) Stock Forecast, Price & News

About CNBX Pharmaceuticals (OTCMKTS:CNBX) Stock

CNBX Stock News Headlines

CNBX Price History

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

CNBX Stock - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info